176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
View analysts' price targets and recommendations, and compare them with competitors.
$207.00
Analysts expect the stock price to increase by 16.41%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
26.97B
Revenue has increased from the previous period.
0.22%
Revenue growth rate has decreased from the previous period.
5.99B
EBITDA has decreased from the previous period.
22.20%
EBITDA margin has decreased from the previous period.
4.44B
EBIT has decreased from the previous period.
16.47%
EBIT margin has decreased from the previous period.
1.54B
Depreciation has increased from the previous period.
13.30B
Total cash has decreased from the previous period.
49.29%
Cash percentage has decreased from the previous period.
3.83B
Receivables have decreased from the previous period.
14.19%
Receivables percentage has decreased from the previous period.
5.16B
Inventories have increased from the previous period.
19.13%
Inventory percentage has increased from the previous period.
1.19B
Accounts payable has decreased from the previous period.
4.42%
Payables percentage has decreased from the previous period.
-1.83B
Capital expenditure has increased from the previous period.
-6.80%
CapEx percentage has increased from the previous period.
12.06%
WACC is unchanged from the previous period.
12.08%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
1.66
Beta is unchanged from the previous period.
24.94B
Diluted shares outstanding is unchanged from the previous period.
11.06B
Total debt is unchanged from the previous period.
3.35T
Total equity is unchanged from the previous period.
3.36T
Total capital is unchanged from the previous period.
0.33%
Debt weighting is unchanged from the previous period.
99.67%
Equity weighting is unchanged from the previous period.
4.64B
EBIAT has decreased from the previous period.
2.03B
UFCF has decreased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
1.62T
Terminal value is unchanged from the previous period.
1.12T
Enterprise value has decreased from the previous period.
3.78B
Net debt is unchanged from the previous period.
1.12T
Equity value has decreased from the previous period.
44.94
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
3.93B
The estimated revenue has increased from the previous period.
566.09M
The estimated EBITDA has decreased from the previous period.
1.05
The estimated EPS has increased from the previous period.
369.97M
The estimated net income has decreased from the previous period.
367.30M
The estimated EBIT has decreased from the previous period.
341.19M
The estimated SG&A expenses have increased from the previous period.
